Loading clinical trials...
Loading clinical trials...
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy: the Model of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors.
Conditions
Interventions
Blood and bone marrow sample
Locations
17
France
CHU Annecy-Genevois
Annecy, France
Institut Bergonié
Bordeaux, France
CHU Caen
Caen, France
CHU de Clermont-Ferrand
Clermont-Ferrand, France
CHU Créteil
Créteil, France
CHU Grenoble Alpes
Grenoble, France
Start Date
November 17, 2023
Primary Completion Date
November 17, 2025
Completion Date
November 17, 2028
Last Updated
September 27, 2024
Lead Sponsor
University Hospital, Clermont-Ferrand
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions